Document is current

Any future updates will be listed below

Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)

Crossref DOI link: https://doi.org/10.1186/s12885-020-6678-x

Published Online: 2020-03-03

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark